655 related articles for article (PubMed ID: 23249967)
1. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
Kwee TC; Torigian DA; Alavi A
J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
[TBL] [Abstract][Full Text] [Related]
2. Nononcological applications of positron emission tomography for evaluation of the thorax.
Kwee TC; Torigian DA; Alavi A
J Thorac Imaging; 2013 Jan; 28(1):25-39. PubMed ID: 23249969
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
4. The pivotal role of FDG-PET/CT in modern medicine.
Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
Rakheja R; Chandarana H; Ponzo F; Seltzer AL; Beltran LS; Geppert C; Friedman KP
PET Clin; 2014 Apr; 9(2):237-52. PubMed ID: 25030285
[TBL] [Abstract][Full Text] [Related]
6. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Wachsmann JW; Gerbaudo VH
PET Clin; 2014 Apr; 9(2):147-68. PubMed ID: 25030279
[TBL] [Abstract][Full Text] [Related]
7. Hybrid PET/MR imaging: physics and technical considerations.
Shah SN; Huang SS
Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
[TBL] [Abstract][Full Text] [Related]
8. Hybrid MR-PET in Neuroimaging.
Bisdas S; Lá Fougere C; Ernemann U
Clin Neuroradiol; 2015 Oct; 25 Suppl 2():275-81. PubMed ID: 26227618
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
Beheshti M; Kim CK
PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
[No Abstract] [Full Text] [Related]
10. 18F-FDG positron emission tomography: potential utility in the assessment of Crohn's disease.
Shyn PB
Abdom Imaging; 2012 Jun; 37(3):377-86. PubMed ID: 21833729
[TBL] [Abstract][Full Text] [Related]
11. Hybrid imaging with PET/MRI: ready for clinical routine?
Ferda J
Eur J Radiol; 2017 Sep; 94():A1-A2. PubMed ID: 28551301
[TBL] [Abstract][Full Text] [Related]
12. Do We Need Yet Another Hybrid Imaging Device?
Divgi C
Acad Radiol; 2016 Feb; 23(2):131. PubMed ID: 26719162
[No Abstract] [Full Text] [Related]
13. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
Højgaard L; Berthelsen AK; Loft A
PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278
[TBL] [Abstract][Full Text] [Related]
14. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
16. The Basic Principles of FDG-PET/CT Imaging.
Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
[TBL] [Abstract][Full Text] [Related]
17. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
[TBL] [Abstract][Full Text] [Related]
18. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.
Kitajima K; Ueno Y; Maeda T; Murakami K; Kaji Y; Kita M; Suzuki K; Sugimura K
Jpn J Radiol; 2011 Nov; 29(9):605-8. PubMed ID: 21956364
[TBL] [Abstract][Full Text] [Related]
20. PET/MRI in Gynecologic Malignancy.
Larson M; Lovrec P; Sadowski EA; Pirasteh A
Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
